1
|
Pei L and Melmed S: Isolation and
characterization of a pituitary tumor-transforming gene (PTTG). Mol
Endocrinol. 11:433–441. 1997. View Article : Google Scholar : PubMed/NCBI
|
2
|
Zhang X, Horwitz GA, Prezant TR, Valentini
A, Nakashima M, Bronstein MD and Melmed S: Structure, expression,
and function of human pituitary tumor-transforming gene (PTTG). Mol
Endocrinol. 13:156–166. 1999. View Article : Google Scholar : PubMed/NCBI
|
3
|
Chen L, Puri R, Lefkowitz EJ and Kakar SS:
Identification of the human pituitary tumor transforming gene
(hPTTG) family: molecular structure, expression, and chromosomal
localization. Gene. 248:41–50. 2000. View Article : Google Scholar : PubMed/NCBI
|
4
|
Hamid T and Kakar SS: PTTG and cancer.
Histol Histopathol. 18:245–251. 2003.
|
5
|
Shah PP, Fong MY and Kakar SS: PTTG
induces EMT through integrin alpha(V)beta(3)-focal adhesion kinase
signaling in lung cancer cells. Oncogene. Nov 14–2011.(E-pub ahead
of print).
|
6
|
Chintharlapalli S, Papineni S, Lee SO, Lei
P, Jin UH, Sherman SI, Santarpia L and Safe S: Inhibition of
pituitary tumor-transforming gene-1 in thyroid cancer cells by
drugs that decrease specificity proteins. Mol Carcinogen.
50:655–667. 2011. View
Article : Google Scholar : PubMed/NCBI
|
7
|
El-Naggar SM, Malik MT and Kakar SS: Small
interfering RNA against PTTG: A novel therapy for ovarian cancer.
Int J Oncol. 31:137–143. 2007.PubMed/NCBI
|
8
|
Yan S, Zhou CQ, Lou XM, Xiao ZF, Zhu HX,
Wang QF, Wang YH, Lu N, He S, Zhan QM, et al: PTTG overexpression
promotes lymph node metastasis in human esophageal squamous cell
carcinoma. Cancer Res. 69:3283–3290. 2009. View Article : Google Scholar : PubMed/NCBI
|
9
|
Jung KW, Park S, Kong HJ, Won YJ, Boo YK,
Shin HR, Park EC and Lee JS: Cancer Statistics in Korea: incidence,
mortality and survival in 2006–2007. J Korean Med Sci.
25:1113–1121. 2010.
|
10
|
Boyle P and Ferlay J: Cancer incidence and
mortality in Europe, 2004. Ann Oncol. 16:481–488. 2005. View Article : Google Scholar : PubMed/NCBI
|
11
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
12
|
Tong Y and Eigler T: Transcriptional
targets for pituitary tumor-transforming gene-1. J Mol Endocrinol.
43:179–185. 2009. View Article : Google Scholar : PubMed/NCBI
|
13
|
Panguluri SK, Yeakel C and Kakar SS: PTTG:
an important target gene for ovarian cancer therapy. J Ovarian Res.
1:62008. View Article : Google Scholar : PubMed/NCBI
|
14
|
Kakar SS and Malik MT: Suppression of lung
cancer with siRNA targeting PTTG. Int J Oncol. 29:387–395.
2006.PubMed/NCBI
|
15
|
Okamura T, Tsujitani S, Korenaga D,
Haraguchi M, Baba H, Hiramoto Y and Sugimachi K: Lymphadenectomy
for cure in patients with early gastric cancer and lymph node
metastasis. Am J Surg. 155:476–480. 1988. View Article : Google Scholar : PubMed/NCBI
|
16
|
Lu CD, Altieri DC and Tanigawa N:
Expression of a novel antiapoptosis gene, survivin, correlated with
tumor cell apoptosis and p53 accumulation in gastric carcinomas.
Cancer Res. 58:1808–1812. 1998.PubMed/NCBI
|
17
|
Salehi F, Kovacs K, Scheithauer BW, Lloyd
RV and Cusimano M: Pituitary tumor-transforming gene in endocrine
and other neoplasms: a review and update. Endocr Relat Cancer.
15:721–743. 2008. View Article : Google Scholar : PubMed/NCBI
|
18
|
Sano T, Sasako M, Kinoshita T and Maruyama
K: Recurrence of early gastric cancer. Follow-up of 1475 patients
and review of the Japanese literature. Cancer. 72:3174–3178. 1993.
View Article : Google Scholar : PubMed/NCBI
|